$26 Million is the total value of Healthcare Value Capital, LLC's 10 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 60.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AGN | Buy | ALLERGAN PLC | $4,392,000 | +64.3% | 30,000 | +50.0% | 16.92% | +62.9% |
| GSK | GLAXOSMITHKLINE PLCsponsored adr | $4,179,000 | +9.4% | 100,000 | 0.0% | 16.10% | +8.4% | |
| TYME | TYME TECHNOLOGIES INC | $3,828,000 | -52.3% | 2,175,000 | 0.0% | 14.75% | -52.7% | |
| GILD | New | GILEAD SCIENCES INC | $3,251,000 | – | 50,000 | +100.0% | 12.53% | – |
| LGND | New | LIGAND PHARMACEUTICALS INCput | $3,143,000 | – | 25,000 | +100.0% | 12.11% | – |
| VKTX | Buy | VIKING THERAPEUTICS INC | $2,485,000 | +224.8% | 250,000 | +150.0% | 9.57% | +221.9% |
| NVLNF | NOVELION THERAPEUTICS INC | $2,214,000 | +43.0% | 1,800,000 | 0.0% | 8.53% | +41.8% | |
| VKTX | VIKING THERAPEUTICS INCcall | $994,000 | +29.9% | 100,000 | 0.0% | 3.83% | +28.8% | |
| ATRS | ANTARES PHARMA INC | $758,000 | +11.5% | 250,000 | 0.0% | 2.92% | +10.5% | |
| ADMS | New | ADAMAS PHARMACEUTICALS INC | $711,000 | – | 100,000 | +100.0% | 2.74% | – |
| LCI | Exit | LANNET INCcall | $0 | – | -25,000 | -100.0% | -0.48% | – |
| BIS | Exit | PROSHARES TRultsh nasd biot | $0 | – | -150,000 | -100.0% | -13.41% | – |
| FLDM | Exit | FLUIDIGM CORP DEL | $0 | – | -450,000 | -100.0% | -15.08% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC | 20 | Q3 2021 | 31.3% |
| GLAXOSMITHKLINE PLC | 20 | Q3 2021 | 16.1% |
| PFIZER INC | 19 | Q3 2021 | 17.9% |
| TYME TECHNOLOGIES INC | 17 | Q3 2021 | 40.3% |
| ASTRAZENECA PLC | 14 | Q3 2021 | 12.9% |
| QUEST DIAGNOSTICS INC | 14 | Q3 2016 | 9.5% |
| CRYOLIFE INC | 13 | Q1 2017 | 6.6% |
| ANTARES PHARMA INC | 13 | Q3 2021 | 6.7% |
| AMARIN CORP PLC | 13 | Q3 2021 | 4.9% |
| CYTOKINETICS INC | 13 | Q3 2016 | 1.7% |
View Healthcare Value Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NOVELION THERAPEUTICS INC. | September 20, 2019 | 1,400,000 | 7.4% |
View Healthcare Value Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-15 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-14 |
| SC 13D/A | 2019-09-20 |
View Healthcare Value Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.